New Adrenaline Devices for Treating Anaphylaxis: Results of a Joint Survey From the European Anaphylaxis Registry and the Allergy‐Vigilance Network

Key Points

• The aim is to evaluate the limitations and expectations of adrenaline auto-injectors from the perspective of allergy-trained physicians.
• Joint survey conducted with input from the European Anaphylaxis Registry and the Allergy-Vigilance Network.
• Sought feedback specifically from allergy specialists regarding adrenaline auto-injectors.
• Identified key limitations of current adrenaline devices.
• Outlined expectations for improvements in new adrenaline devices.
• Emphasized the need for more clinical data from anaphylaxis patients.